International Journal of Drug Policy
Volume 21, Issue 5 , Pages 345-346, September 2010

The risk of using paid plasma

  • Patricia Volkow

      Affiliations

    • Instituto Nacional de Cancerología, Mexico City, Mexico
    • ,
  • Kimberly C. Brouwer

      Affiliations

    • University of California San Diego School of Medicine, Division of Global Public Health, La Jolla, CA, United States
    • ,
  • Richard S. Garfein

      Affiliations

    • University of California San Diego School of Medicine, Division of Global Public Health, La Jolla, CA, United States
    • ,
  • Steffanie A. Strathdee

      Affiliations

    • University of California San Diego School of Medicine, Division of Global Public Health, La Jolla, CA, United States
    • Corresponding Author InformationCorresponding author at: Division of Global Public Health, University of California, San Diego School of Medicine, 9500 Gilman Drive, MC 0622, La Jolla, CA 92093-0622, United States. Tel.: +1 858 822 6468; fax: +1 858 822 4642.

Received 19 May 2010; accepted 21 May 2010. published online 21 June 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0955-3959(10)00076-9

doi:10.1016/j.drugpo.2010.05.002

International Journal of Drug Policy
Volume 21, Issue 5 , Pages 345-346, September 2010

Article Tools